Information about Acura Pharma
My details
*
*
*

Acura Pharma (SPRL)

BE 0468.913.836

Rue Drootbeek 91, 1020 Bruxelles

Company information

Status
Active

Enterprise number

BE0468.913.836

VAT liability
Yes
Established
16-12-1999
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Acura Pharma

2024 2023 2022 2021
Profit/Loss € 110,735 22 % € 90,426 -33 % € 135,505 426 % € 25,755
Equity € 33,733 2 % € 32,998 46 % € 22,572 -81 % € 117,067
Gross margin € 176,002 17 % € 150,629 -28 % € 210,489 237 % € 62,517

Publications from Acura Pharma

Date Publication
20-08-2014 Designation - Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
30-05-2008 Resignations - Appointments (NL)
28-04-2000 Rapport(s) Me. (FR)
07-01-2000 Constitution (NL)

Frequently asked questions

What is the VAT number of Acura Pharma?
The VAT number of Acura Pharma is BE 0468.913.836.
Wat is the PEPPOL ID of Acura Pharma?
The PEPPOL ID of Acura Pharma is 0208:0468913836. Log in or start a free trial to see the full overview.
When was Acura Pharma founded?
Acura Pharma was founded on 16-12-1999.
What is the address of Acura Pharma?
The current registered office of Acura Pharma is located at Rue Drootbeek 91, 1020 Bruxelles.
When was the last time Acura Pharma filed their annual financial statements?
The most recent financial statements of Acura Pharma were filed on 31-07-2025.
How many employees does Acura Pharma have?
There are currently no employees working at Acura Pharma or no workforce information is available.
What is the annual turnover of Acura Pharma?
At the time of its most recent financial statements, Acura Pharma did not publish any turnover figures. Acura Pharma reported a gross margin of €176,002.45.

Sources